Abstract

Iron is essential for growth of Mycobacterium tuberculosis, the causative agent of tuberculosis. To acquire iron from the host, M. tuberculosis uses the siderophores called mycobactins and carboxymycobactins. Here, we show that the rv0455c gene is essential for M. tuberculosis to grow in low-iron medium and that secretion of both mycobactins and carboxymycobactins is drastically reduced in the rv0455c deletion mutant. Both water-soluble and membrane-anchored Rv0455c are functional in siderophore secretion, supporting an intracellular role. Lack of Rv0455c results in siderophore toxicity, a phenotype observed for other siderophore secretion mutants, and severely impairs replication of M. tuberculosis in mice, demonstrating the importance of Rv0455c and siderophore secretion during disease. The crystal structure of a Rv0455c homolog reveals a novel protein fold consisting of a helical bundle with a ‘cinch’ formed by an essential intramolecular disulfide bond. These findings advance our understanding of the distinct M. tuberculosis siderophore secretion system.

The pathogen Mycobacterium tuberculosis uses the siderophores called mycobactins and carboxymycobactins to acquire iron from the host. Here, Zhang et al. identify a protein that is important for siderophore secretion and for the pathogen’s growth in low-iron medium.

Details

Title
A periplasmic cinched protein is required for siderophore secretion and virulence of Mycobacterium tuberculosis
Author
Zhang, Lei 1   VIAFID ORCID Logo  ; Kent, James E 2   VIAFID ORCID Logo  ; Whitaker, Meredith 3 ; Young, David C 4 ; Herrmann, Dominik 1   VIAFID ORCID Logo  ; Aleshin, Alexander E 2 ; Ying-Hui, Ko 5 ; Cingolani Gino 5   VIAFID ORCID Logo  ; Saad, Jamil S 1   VIAFID ORCID Logo  ; Branch, Moody D 4   VIAFID ORCID Logo  ; Marassi, Francesca M 2 ; Ehrt Sabine 3   VIAFID ORCID Logo  ; Niederweis, Michael 1   VIAFID ORCID Logo 

 University of Alabama at Birmingham, Department of Microbiology, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187) 
 Sanford Burnham Prebys Medical Discovery Institute, Cancer Center, La Jolla, USA (GRID:grid.479509.6) (ISNI:0000 0001 0163 8573) 
 Weill Cornell Medical College, Department of Microbiology and Immunology, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 Harvard Medical School, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Thomas Jefferson University, Department of Biochemistry and Molecular Biology, Philadelphia, USA (GRID:grid.265008.9) (ISNI:0000 0001 2166 5843) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2655335670
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.